Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 2, 2007, Pages 788-792

  Elbarbry, Fawzy A ^a   Shoker, Ahmed ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

HPLC; Mycophenolic acid; Renal transplant; Validation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN;

ANALYTIC METHOD; ARTICLE; CALIBRATION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; PH; PLASMA; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE DRUG DOSE; STANDARD;

ACETONITRILES; BUFFERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LINEAR MODELS; MYCOPHENOLIC ACID; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33845604117     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.08.012     Document Type: Article

References (22)

1. van Gelder T. Am. J. Transplant. 5 (2005) 199-200
2. Shaw L.M., Korecka M., Venkataramanan R., Goldberg L., Bloom R., and Brayman K.L. Am. J. Transplant. 3 (2003) 534-542
3. Budde K., Curtis J., Knoll G., Chan L., Neumayer H.H., Seifu Y., and Hall M. Am. J. Transplant. 4 (2004) 237-243
4. Srinivas T.R., Meier-Kriesche H.U., and Kaplan B. Am. J. Transplant. 5 (2005) 207-217
5. Glander P., Hambach P., Braun K.P., Fritsche L., Giessing M., Mai I., Einecke G., Waiser J., Neumayer H.H., and Budde K. Am. J. Transplant. 4 (2004) 2045-2051
6. Gerbase M.W., Fathi M., Spiliopoulos A., Rochat T., and Nicod L.P. J. Heart Lung Transplant. 22 (2003) 587-590
7. Tredger J.M., and Brown N.W. Transplantation 81 (2006) 507-508
8. Fulton B., and Markham A. Drugs 51 (1996) 278-298
9. Bullingham R., Monroe S., Nicholls A., and Hale M. J. Clin. Pharmacol. 36 (1996) 315-324
10. Barkozi M., Rouni M., and Rezaee S. DARU 13 (2005) 120-126
11. Shipkova M., Niedmann P.D., Armstrong V.W., Schutz E., Wieland E., Shaw L.M., and Oellerich M. Clin. Chem. 44 (1998) 1481-1488
12. Bolon M., Jeanpierre L., El Barkil M., Chelbi K., Sauviat M., and Boulieu R. J. Pharm. Biomed. Anal. 36 (2004) 649-651
13. Westley I.S., Sallustio B.C., and Morris R.G. Clin. Biochem. 38 (2005) 824-829
14. Shipkova M., Armstrong V.W., Kiehl M.G., Niedmann P.D., Schutz E., Oellerich M., and Wieland E. Clin. Chem. 47 (2001) 1485-1488
15. Millan O., Brunet M., Martorell J., Garcia F., Vidal E., Rojo I., Plana M., Gallart T., Pumarola T., Miro J.M., and Gatell J.M. Clin. Pharmacokinet. 44 (2005) 525-538
16. Teshima D., Kitagawa N., Otsubo K., Makino K., Itoh Y., and Oishi R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 780 (2002) 21-26
17. Pastore A., Lo R.A., Piemonte F., Mannucci L., and Federici G. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 776 (2002) 251-254
18. Hosotsubo H., Takahara S., Imamura R., Kyakuno M., Tanaka T., Yazawa K., Hanafusa T., Matsumiya K., Nonomura N., Okuyama A., and Sugimoto H. Ther. Drug Monit. 23 (2001) 669-674
19. Shipkova M., Schutz E., Armstrong V.W., Niedmann P.D., Oellerich M., and Wieland E. Clin. Chem. 46 (2000) 365-372
20. Mendonza A.E., Gohh R.Y., and Akhlaghi F. Ther. Drug Monit. 28 (2006) 402-406
21. Premaud A., Rousseau A., Picard N., and Marquet P. Ther. Drug Monit. 28 (2006) 274-277
22. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., and McDowall R.D. Eur. J. Drug Metab. Pharmacokinet. 16 (1991) 249-255